scholarly article | Q13442814 |
P2093 | author name string | Foster PS | |
Shepherd DP | |||
Hogan SP | |||
Kumar RK | |||
Temelkovski J | |||
P2860 | cites work | Eosinophilic Inflammation in Asthma | Q29031455 |
Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness | Q33665320 | ||
Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma | Q35996490 | ||
Pathology of asthma | Q36262188 | ||
Asthma. Epithelial cells | Q36262224 | ||
Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model | Q36366104 | ||
Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. | Q36366158 | ||
Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins | Q37365236 | ||
Bronchial hyperresponsiveness: the need for a distinction between hypersensitivity and excessive airway narrowing | Q38643107 | ||
Animal models of occupational asthma | Q40662563 | ||
Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. | Q40768651 | ||
Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. | Q40791336 | ||
The relevance of murine animal models to study the development of allergic bronchial asthma | Q41046427 | ||
Pathology of mild, severe, and fatal asthma | Q41075223 | ||
"Ultimate activation" of eosinophils in vivo: lysis and release of clusters of free eosinophil granules (Cfegs) | Q41535089 | ||
Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice | Q42947781 | ||
Effect of acute and chronic antigen inhalation on airway morphology and responsiveness in actively sensitized rats | Q44165838 | ||
Attenuation of allergic airway inflammation in IL-4 deficient mice | Q49112216 | ||
Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects | Q49280491 | ||
Airway mucosal inflammation even in patients with newly diagnosed asthma. | Q51670975 | ||
Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice. | Q54155075 | ||
Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. | Q54185709 | ||
Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. | Q54268935 | ||
Susceptibility to experimental interstitial lung disease is modified by immune- and non-immune-related genes. | Q54413019 | ||
Airway reactivity in ponies with recurrent airway obstruction (heaves). | Q54455049 | ||
Characterization of allergen-induced bronchial hyperresponsiveness and airway inflammation in actively sensitized Brown-Norway rats | Q57085092 | ||
Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells | Q59310681 | ||
Relationship between IL-4 and IL-5 mRNA Expression and Disease Severity in Atopic Asthma | Q61895278 | ||
Asthma | Q67595530 | ||
Endotoxins in inhalation research. Summary of conclusions of a workshop held at Clearwater, Florida, U.S.A., 28-30 September 1987 | Q68035689 | ||
Toward a definition of asthma for epidemiology | Q68037965 | ||
The mechanics of airway narrowing in asthma | Q69938618 | ||
Cellular events in the bronchi in mild asthma and after bronchial provocation | Q69960302 | ||
Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice | Q70511277 | ||
Enzyme complex amplification--a signal amplification method for use in enzyme immunoassays | Q70642555 | ||
The role of 5-lipoxygenase products in preclinical models of asthma | Q70660902 | ||
Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen | Q70684112 | ||
Lung inflammation and epithelial changes in a murine model of atopic asthma | Q71065076 | ||
Measurement of low-frequency respiratory impedance in infants | Q71189405 | ||
Mouse models of allergic disease; how do they relate to asthma in man? | Q71538074 | ||
Alveolar tissue inflammation in asthma | Q71767468 | ||
Seasonal comparison of cytokine profiles in atopic asthmatics and atopic non-asthmatics | Q71906919 | ||
Characterization of a murine model of allergic pulmonary inflammation | Q72190775 | ||
Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness | Q72300760 | ||
Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study | Q72918050 | ||
Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody | Q73326142 | ||
Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation | Q73359111 | ||
Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography | Q73730758 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | asthma | Q35869 |
murine model | Q122890741 | ||
P304 | page(s) | 849-856 | |
P577 | publication date | 1998-10-01 | |
P1433 | published in | Thorax | Q7796158 |
P1476 | title | An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen | |
P478 | volume | 53 |
Q45981614 | 1,25-Dihydroxyvitamin D(3) (1,25-(OH)(2)D(3)) attenuates airway remodeling in a murine model of chronic asthma. |
Q47100403 | A 3D epithelial-mesenchymal co-culture model of human bronchial tissue recapitulates multiple features of airway tissue remodeling by TGF-β1 treatment. |
Q43423470 | Absence of respiratory inflammatory reaction of elemental sulfur using the California Pesticide Illness Database and a mouse model |
Q37137320 | Airway and lung pathology due to mucosal surface dehydration in {beta}-epithelial Na+ channel-overexpressing mice: role of TNF-{alpha} and IL-4R{alpha} signaling, influence of neonatal development, and limited efficacy of glucocorticoid treatment |
Q46027211 | Airway fibrosis in a mouse model of airway inflammation. |
Q37657084 | Airway remodeling in asthma: what really matters |
Q35878502 | Airway remodeling: lessons from animal models |
Q39670944 | Airway responsiveness after acute exposure to urban particulate matter 1648 in a DO11.10 murine model |
Q48029209 | Airway smooth muscle cells from ovalbumin-sensitized mice show increased proliferative response to TGFβ1 due to upregulation of Smad3 and TGFβRII. |
Q34206747 | Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice. |
Q33934140 | Aligning mouse models of asthma to human endotypes of disease |
Q33909356 | Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target |
Q34162303 | Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma |
Q28652444 | Ambient particulate matter induces an exacerbation of airway inflammation in experimental asthma: role of interleukin-33 |
Q37105629 | An alpha4beta1 integrin antagonist decreases airway inflammation in ovalbumin-exposed mice |
Q35484382 | Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation |
Q43065050 | Animal models of chronic experimental asthma - strategies for the identification of new therapeutic targets |
Q28540323 | Anti-inflammatory and anti-remodelling effects of ISU201, a modified form of the extracellular domain of human BST2, in experimental models of asthma: association with inhibition of histone acetylation |
Q35607608 | Antiasthmatic Effects of Herbal Complex MA and Its Fermented Product MA128. |
Q55485718 | Antiasthmatic Effects of Sanglong Pingchuan Decoction through Inducing a Balanced Th1/Th2 Immune Response. |
Q36282984 | Are mouse models of asthma appropriate for investigating the pathogenesis of airway hyper-responsiveness? |
Q39287243 | Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. |
Q44086872 | Asymptomatic worsening of airway inflammation during low-dose allergen exposure in asthma: protection by inhaled steroids |
Q29248141 | Barriers to inhaled gene therapy of obstructive lung diseases: A review |
Q83892144 | Blocking induction of T helper type 2 responses prevents development of disease in a model of childhood asthma |
Q36062587 | Building better mouse models of asthma |
Q43957822 | CD4(+) T-lymphocytes regulate airway remodeling and hyper-reactivity in a mouse model of chronic asthma. |
Q51110441 | Characterization of a novel model incorporating airway epithelial damage and related fibrosis to the pathogenesis of asthma. |
Q35745429 | Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus |
Q57203119 | Chronic intranasal administration of mould spores or extracts to unsensitized mice leads to lung allergic inflammation, hyper-reactivity and remodelling |
Q38781893 | Cigarette smoke enhances Th-2 driven airway inflammation and delays inhalational tolerance. |
Q43997164 | Cigarette smoke-induced airway hyperresponsiveness is not dependent on elevated immunoglobulin and eosinophilic inflammation in a mouse model of allergic airway disease |
Q43719593 | Combination therapy with relaxin and methylprednisolone augments the effects of either treatment alone in inhibiting subepithelial fibrosis in an experimental model of allergic airways disease |
Q27332407 | Compartmental and temporal dynamics of chronic inflammation and airway remodelling in a chronic asthma mouse model |
Q33977282 | Consequences of long-term inflammation. Airway remodeling |
Q44641935 | Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling |
Q37260860 | Cumulative environmental changes, skewed antigen exposure, and the increase of allergy |
Q34903133 | Cytokine/anti-cytokine therapy - novel treatments for asthma? |
Q33733234 | Delivery of adipose-derived mesenchymal stem cells attenuates airway responsiveness and inflammation in a mouse model of ovalbumin-induced asthma |
Q54528175 | Depletion of CD8+ T cells enhances airway remodelling in a rodent model of asthma. |
Q33514105 | Derivation and validation of murine histologic alterations resembling asthma, with two proposed histologic grade parameters |
Q36683087 | Development of asthmatic inflammation in mice following early-life exposure to ambient environmental particulates and chronic allergen challenge |
Q51692395 | Development of sensitisation or tolerance following repeated OVA inhalation in BALB/cJ mice. Dose-dependency and modulation by the Al(OH)3 adjuvant. |
Q73833089 | Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma |
Q33741672 | Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice |
Q36953178 | Effect of carvacrol on various cytokines genes expression in splenocytes of asthmatic mice |
Q51279385 | Effect of mesenchymal stem cells on inhibiting airway remodeling and airway inflammation in chronic asthma. |
Q34687375 | Effect of physical training on airway inflammation in animal models of asthma: a systematic review |
Q46490838 | Effect of tranilast in comparison with beclomethasone in chronic murine model of asthma |
Q53365576 | Effect of β-glucan originated from Aureobasidium pullulans on asthma induced by ovalbumin in mouse. |
Q58049795 | Effects of the Histone Deacetylase Inhibitor, Trichostatin A, in a Chronic Allergic Airways Disease Model in Mice |
Q46319705 | Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma |
Q77932340 | Eotaxin expression by epithelial cells and plasma cells in chronic asthma |
Q38056181 | Exposure of immunologically naive laboratory rodents to antigen via the airways. Where does tolerance stop and sensitization begin? |
Q36238055 | Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma |
Q48623458 | Fractionated irradiations lead to chronic allergic airway inflammation through increasing the influx of macrophages |
Q37943847 | Fungi linking the pathophysiology of chronic rhinosinusitis with nasal polyps and allergic asthma |
Q51703541 | General and Specific Mouse Models for Asthma Research. |
Q37642503 | Glycyrrhizin and long-term histopathologic changes in a murine model of asthma |
Q37321867 | HSP70/CD80 DNA vaccine inhibits airway remodeling by regulating the transcription factors T-bet and GATA-3 in a murine model of chronic asthma |
Q35125317 | ISU201 enhances the resolution of airway inflammation in a mouse model of an acute exacerbation of asthma. |
Q35864971 | Immunolocalization of NLRP3 Inflammasome in Normal Murine Airway Epithelium and Changes following Induction of Ovalbumin-Induced Airway Inflammation |
Q37144545 | Importance of myeloid dendritic cells in persistent airway disease after repeated allergen exposure |
Q46052640 | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model |
Q37596511 | In utero exposure to second-hand smoke aggravates the response to ovalbumin in adult mice |
Q45763812 | Influence of inhaled beclomethasone and montelukast on airway remodeling in mice |
Q81470399 | Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae |
Q35884617 | Initial observations of cell-mediated drug delivery to the deep lung |
Q42181941 | Interleukin-33 drives activation of alveolar macrophages and airway inflammation in a mouse model of acute exacerbation of chronic asthma |
Q77856796 | Interleukin-5 and eosinophils as therapeutic targets for asthma |
Q51121563 | Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways disease. |
Q51662353 | Intraperitoneal mesenchymal stem cell administration ameliorates allergic rhinitis in the murine model. |
Q36081902 | Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model |
Q58795805 | Intratracheal administration of adipose derived mesenchymal stem cells alleviates chronic asthma in a mouse model |
Q42530785 | Intratracheal instillation of pravastatin for the treatment of murine allergic asthma: a lung-targeted approach to deliver statins |
Q39402859 | Modeling TH 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma |
Q34805236 | Modeling allergic asthma in mice: pitfalls and opportunities |
Q51653665 | Morphometric analysis of mouse airways after chronic allergen challenge. |
Q26765990 | Mouse models of acute exacerbations of allergic asthma |
Q34212495 | Mouse models of allergic airway disease |
Q37353895 | Mouse models of allergic asthma: acute and chronic allergen challenge |
Q39237092 | Mouse models of severe asthma: Understanding the mechanisms of steroid resistance, tissue remodelling and disease exacerbation |
Q37809217 | Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance |
Q34192921 | Murine model of chronic human asthma. |
Q37859521 | Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. |
Q41891749 | Nitric oxide synthase enzymes in the airways of mice exposed to ovalbumin: NOS2 expression is NOS3 dependent |
Q42261660 | Nogo-B regulates migration and contraction of airway smooth muscle cells by decreasing ARPC 2/3 and increasing MYL-9 expression |
Q36193355 | Overexpression of programmed cell death 5 in a mouse model of ovalbumin-induced allergic asthma |
Q43991324 | PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model |
Q47767965 | Penh is not a validated technique for measuring airway function in mice |
Q37754996 | Preclinical animal models of asthma and chronic obstructive pulmonary disease |
Q33872051 | Prenatal allergen and diesel exhaust exposure and their effects on allergy in adult offspring mice |
Q78850530 | Proceedings of the first Jack Pepys Occupational Asthma Symposium |
Q56834648 | Profibrotic Effect of IL-9 Overexpression in a Model of Airway Remodeling |
Q36193173 | Prolonged allergen challenge in mice leads to persistent airway remodelling. |
Q49169342 | Prolonged allergen exposure induces structural airway changes in sensitized rats |
Q43162277 | Prolonged ovalbumin challenge facilitates Th17 polarization in sensitized mice |
Q25256965 | Prolonged ozone exposure in an allergic airway disease model: adaptation of airway responsiveness and airway remodeling |
Q97420223 | Proteomics profiling asthma induced-lysine acetylation |
Q28573585 | Proximal airway mucous cells of ovalbumin-sensitized and -challenged Brown Norway rats accumulate the neuropeptide calcitonin gene-related peptide |
Q24804158 | Quantification of collagen and proteoglycan deposition in a murine model of airway remodelling |
Q36573298 | Recurring BALB/c mouse lung inflammatory responses to episodic allergen exposure |
Q33318473 | Reduced lung function in a chronic asthma model is associated with prolonged inflammation, but independent of peribronchial fibrosis |
Q46375181 | Repeated inhalation challenge with diphenylmethane-4,4'-diisocyanate in brown Norway rats leads to a time-related increase of neutrophils in bronchoalveolar lavage after topical induction |
Q39042664 | Resolvin E1 promotes resolution of inflammation in a mouse model of an acute exacerbation of allergic asthma |
Q36159665 | Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways disease |
Q43100120 | Reversal of methylprednisolone effects in allergen-exposed female BALB/c mice |
Q38864968 | Review of Mouse Models Applied to the Study of Asthma |
Q42393166 | Role of inducible nitric oxide synthase on the development of virus-associated asthma exacerbation which is dependent on Th1 and Th17 cell responses |
Q40485763 | Selective targeting of CREB-binding protein/β-catenin inhibits growth of and extracellular matrix remodelling by airway smooth muscle |
Q28534642 | Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation |
Q37423130 | Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond |
Q41557551 | Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling? |
Q36623919 | Sinomenine attenuates airway inflammation and remodeling in a mouse model of asthma |
Q92130987 | Smooth-muscle-derived WNT5A augments allergen-induced airway remodelling and Th2 type inflammation |
Q37098449 | Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma |
Q89621756 | Study of a BALB/c Mouse Model for Allergic Asthma |
Q44547056 | Susceptibility to ovalbumin-induced airway inflammation and fibrosis in inducible nitric oxide synthetase-deficient mice: mechanisms and consequences |
Q45001530 | T-cell-mediated inflammation does not contribute to the maintenance of airway dysfunction in mice |
Q43059347 | TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice |
Q37056577 | Targeting eosinophils in asthma |
Q40086497 | The Effect of Zataria multiflora on Th1/Th2 and Th17/T Regulatory in a Mouse Model of Allergic Asthma. |
Q24550856 | The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation |
Q34620166 | The contribution of L-selectin to airway hyperresponsiveness in chronic allergic airways disease |
Q43689845 | The effect of rupatadine on lung histopathology in a murine model of chronic asthma. |
Q83150383 | The effects of triptolide on airway remodelling and transforming growth factor-β₁/Smad signalling pathway in ovalbumin-sensitized mice |
Q51701514 | The involvement of matrix metalloproteinases in basement membrane injury in a murine model of acute allergic airway inflammation. |
Q24799142 | The pattern of methacholine responsiveness in mice is dependent on antigen challenge dose |
Q50510777 | The role of bone marrow-derived adult stem cells in a transgenic mouse model of allergic asthma. |
Q37358582 | Therapeutic effects of histone deacetylase inhibitors in a murine asthma model |
Q37220309 | Time sequence of airway remodeling in a mouse model of chronic asthma: the relation with airway hyperresponsiveness |
Q51636510 | Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. |
Q34453206 | Understanding airway wall remodeling in asthma: a basis for improvements in therapy? |
Q33701214 | Understanding asthma using animal models |
Q34349777 | Understanding the pathogenesis of allergic asthma using mouse models |
Q41560889 | Vascular endothelial growth factor antagonism restores epithelial barrier dysfunction via affecting zonula occludens proteins. |
Q24791345 | What have transgenic and knockout animals taught us about respiratory disease? |
Q84290562 | [Again an asthma model... but a useful one] |
Q51075244 | [Effect of montelukast sodium intervention on airway remodeling and percentage of Th17 cells/CD4+CD25+ regulatory T cells in asthmatic mice]. |
Q50946913 | [HMGB1/TLR4/NF-κB signaling pathway and role of vitamin D in asthmatic mice]. |
Q81520330 | [Use of the mouse to unravel allergic asthma: a review of the pathogenesis of allergic asthma in mouse models and its similarity to the condition in humans] |
Search more.